Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion

A Randomized Controlled Trial of 2 Different Methods for Pain Relief During Intrauterine Device Insertion

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02714231

Enrollment

100

Registered

2016-03-21

Start date

2016-03-31

Completion date

2017-03-31

Last updated

2017-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Family Planning

Brief summary

The aim of our study is to compare the analgesic effect of oral diclofenac sodium versus oral hyoscine butyl bromide during intrauterine device insertion.

Interventions

DRUGdiclofenac sodium (cataflam)

The patients in the study group will take one tablet of cataflam 50 mg 30 min before the scheduled time of the procedure

DRUGhyoscine butyl bromide (buscopan)

The patients in the study group will take one tablet of buscopan 10 mg 30 min before the scheduled time of the procedure

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 50 Years

Healthy volunteers

Inclusion criteria

* Women not taken analgesics or anxiolytics in the 24 hours prior insertion * Women not taken misoprostol prior to intrauterine device insertion * Women who will accept to participate in the study

Exclusion criteria

* Any contraindication to intrauterine device placement

Design outcomes

Primary

Measure	Time frame
Mean pain score during insertion	intraoperative

Secondary

Measure	Time frame
Patient satisfaction score	5 minutes

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026